Sprint Bioscience AB (publ) (FRA:5JA1)

Sprint Bioscience AB Statistics

Total Valuation

FRA:5JA1 has a market cap or net worth of EUR 15.04 million. The enterprise value is 14.05 million.

Market Cap	15.04M
Enterprise Value	14.05M

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	105.52M
Shares Outstanding	n/a
Shares Change (YoY)	+19.80%
Shares Change (QoQ)	+18.51%
Owned by Insiders (%)	23.63%
Owned by Institutions (%)	12.05%
Float	70.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	18.31
PS Ratio	3.32
PB Ratio	27.43
P/TBV Ratio	27.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.05
EV / Sales	3.08
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.98

Financial Position

The company has a current ratio of 1.13

Current Ratio	1.13
Quick Ratio	1.13
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-17.99

Financial Efficiency

Return on equity (ROE) is -262.44% and return on invested capital (ROIC) is -155.00%.

Return on Equity (ROE)	-262.44%
Return on Assets (ROA)	-44.91%
Return on Invested Capital (ROIC)	-155.00%
Return on Capital Employed (ROCE)	-399.70%
Revenue Per Employee	119,076
Profits Per Employee	-61,054
Employee Count	38
Asset Turnover	1.48
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.02% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+2.02%
50-Day Moving Average	0.05
200-Day Moving Average	0.04
Relative Strength Index (RSI)	83.57
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:5JA1 had revenue of EUR 4.52 million and -2.32 million in losses. Loss per share was -0.03.

Revenue	4.52M
Gross Profit	2.82M
Operating Income	-2.19M
Pretax Income	-2.32M
Net Income	-2.32M
EBITDA	-2.12M
EBIT	-2.19M
Loss Per Share	-0.03

Balance Sheet

The company has 990,346 in cash and n/a in debt, giving a net cash position of 990,346.

Cash & Cash Equivalents	990,346
Total Debt	n/a
Net Cash	990,346
Net Cash Per Share	n/a
Equity (Book Value)	548,494
Book Value Per Share	0.01
Working Capital	183,434

Cash Flow

In the last 12 months, operating cash flow was -3.48 million and capital expenditures -51,557, giving a free cash flow of -3.53 million.

Operating Cash Flow	-3.48M
Capital Expenditures	-51,557
Free Cash Flow	-3.53M
FCF Per Share	n/a

Margins

Gross margin is 62.27%, with operating and profit margins of -48.45% and -51.27%.

Gross Margin	62.27%
Operating Margin	-48.45%
Pretax Margin	-51.27%
Profit Margin	-51.27%
EBITDA Margin	-46.78%
EBIT Margin	-48.45%
FCF Margin	n/a

Dividends & Yields

FRA:5JA1 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.80%
Shareholder Yield	-19.80%
Earnings Yield	-15.42%
FCF Yield	-23.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:5JA1 has an Altman Z-Score of -17.3 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-17.3
Piotroski F-Score	2